S epsis is the major cause of death in patients admitted to the ICU worldwide. According to a European multicenter observational study, 37.4% of patients admitted to the ICU had sepsis (1) . ICU and in-hospital mortality rates of sepsis were as high as 39.2% and 49.6%, respectively, which are still high rates (2) . A substantial number of these patients develop severe sepsis and septic shock. Furthermore, stepwise increases were found in mortality rates in the hierarchy from systemic inflammatory response syndrome (SIRS) to sepsis, severe sepsis, and septic shock: 7%, 16%, 20%, and 46%, respectively (3) . Therefore, it is important for physicians to evaluate the severity of illness and predict prognosis exactly in the early phase of sepsis. Several outcome prediction models, such as the Acute Objective: Sepsis is the leading cause of death among critically ill patients. There are, however, few appropriate biomarkers to predict mortality in patients with sepsis. We focused on maximal chemiluminescent intensity in response to lipopolysaccharide assessed by endotoxin activity assay and evaluated the diagnostic value of maximal chemiluminescent intensity on admission day as a predictor of mortality in patients with sepsis. Design: Prospective, observational study. Setting: ICU. Patients: One hundred and thirty-two patients with sepsis. Interventions: None. Measurements and Main Results: Within 12 hours after admission, a whole-blood sample was collected, and variables assessed by endotoxin activity assay were measured in each patient. Severity of illness was assessed simultaneously by Acute Physiology and Chronic Health Evaluation (APACHE) II score and Sequential Organ Failure Assessment (SOFA) score. The primary outcome was 28-day mortality. One hundred and fifteen patients survived and 17 died. maximal chemiluminescent intensity values were significantly lower in the nonsurvivors than in the survivors (p <0.05).
We investigated maximal chemiluminescent intensity, APACHE II score, and SOFA score as predictors of 28-day mortality. Receiver operating characteristic analysis showed that area under the curve for maximal chemiluminescent intensity was 0.902, which was superior to the area under the curves for APACHE II score (0.836) and SOFA score (0.807). At the optimal cutoff value for maximal chemiluminescent intensity, 21,000 RLU/s, the sensitivity for correct prediction of 28-day mortality was 82.4% and the specificity was 92.2%. Kaplan-Meier analysis showed that low maximal chemiluminescent intensity (<21,000 RLU/s) closely correlated with poor overall patient survival compared with high maximal chemiluminescent intensity (>21,000 RLU/s) (p <0.001 by logrank test). After adjusting for APACHE II score by Cox regression analysis, maximal chemiluminescent intensity was identified as an independent predictor for the probability of 28-day mortality. Conclusion: Maximal chemiluminescent intensity level measured on admission day appears to have high predictive value for mortality in patients with sepsis. ( Physiology and Chronic Health Evaluation (APACHE) II score and the Sequential Organ Failure Assessment (SOFA) score, are available that calculate a prediction on the basis of values measured within the first 24 hours of an ICU stay (4, 5) . In addition, single biomarkers of sepsis, such as cytokines or procalcitonin, are useful to identify sepsis (6, 7) . However, none have sufficient sensitivity and specificity to predict prognosis of patients with sepsis (8) . A combination of several biomarkers of sepsis may be effective (9) , but this requires further evaluation.
The endotoxin activity assay (EAA) is a whole-blood assay for the detection of lipopolysaccharide (10) . This method utilizes the CR1 and CR3 receptor-induced oxidant production of polymorphonuclear leucocytes as a detection platform. The lipopolysaccharide/antilipopolysaccharide complex primes the patient's neutrophils for an augmented response to stimulation with zymosan. By measuring basal (no antibody) and maximally stimulated (4.6 ng/mL lipopolysaccharide) responses in the same blood sample, the endotoxin activity (EA) level of the test specimen can be calculated by integrating the chemiluminescence over time. EA level is expressed in relative units derived from the integral of the basal and stimulated chemiluminescent responses. EA level has been reported to correlate with severity of illness in critically ill patients and is applied in clinical settings (11) . In our preliminary study, we found that the maximal chemiluminescent intensity in response to lipopolysaccharide assessed by EAA on admission day was markedly decreased in most of the nonsurvivors with sepsis, whereas the EA level varied among patients; therefore, we decided to conduct an additional study.
Thus, the purpose of the present study was to evaluate the diagnostic value of maximal chemiluminescent intensity in response to lipopolysaccharide assessed by EAA on ICU admission day to predict mortality in patients with sepsis.
MATERIALS AND METHODS

Study Population
This study was a prospective observational study conducted at the Department of Emergency and Critical Care, Osaka General Medical Center, over a period of 26 months from September 2009 to November 2011. The criteria for inclusion were sepsis diagnosed on admission and age older than 18 years. Sepsis was defined as a systemic response to infection including the criteria for SIRS plus microbiological evidence of a focal infection and/or a positive blood culture. Severe sepsis was defined as sepsis associated with organ dysfunction, hypoperfusion abnormality, or sepsis-induced hypotension. Septic shock was defined as sepsis-induced hypotension, persisting despite adequate fluid resuscitation, along with the presence of hypoperfusion abnormalities or organ dysfunction. Patients were considered to have SIRS if they met the criteria defined in the guidelines of the American College of Chest Physicians/ Society of Critical Care Medicine (12) . The criterion for exclusion was end-stage cancer.
All patients were principally treated according to the strategy of the Surviving Sepsis Campaign Guidelines (13) . We did not administer recombinant human activated protein C because its use has not been approved for the treatment of sepsis in Japan. This study followed the principles of the Declaration of Helsinki, and the conduction of this study was approved by the institutional review board at Osaka General Medical Center. Informed consent was obtained from all patients or the next of kin if patients were unconscious.
Data Collection
The variables used to assess comparability were age, sex, APACHE II score, SOFA score, and site of infection. A wholeblood sample was collected within 12 hours after admission. Variables assessed by the chemiluminescent EAA (Spectral Diagnostics, Toronto, ON, Canada), WBC counts, and C-reactive protein levels were measured. The prognosis of patients was followed until 28 days after entry into the study.
The methodology of EAA is described in detail elsewhere (10, 11) ( Fig. 1) . Briefly, 50-μL samples of whole blood and appropriate controls were incubated in duplicate with saturating concentrations of an anti-lipid A IgM antibody and then stimulated with opsonized zymosan. The resulting respiratory burst activity was detected as light release from the lumiphor luminol by a chemiluminometer (Autolumat LB953; Berthold Technologies, Bad Wildbad, Germany). By measuring basal and maximally stimulated responses, EA level is expressed in relative units derived from the integral of the basal and stimulated chemiluminescent responses. In addition, we focused on the maximal chemiluminescent intensity in response to lipopolysaccharide and termed this value "CI max."
Statistical Analysis
Data are expressed as group medians with interquartile ranges or as numbers with percentages as appropriate. Continuous variables were compared between groups with the Mann-Whitney U test. Categorical variables were analyzed with the chi-square test or Fisher's exact test as appropriate. Figure 1 . Methodology of endotoxin activity assay. Endotoxin activity level is calculated by normalizing the chemiluminescent intensity (CI) in the test sample against the maximal CI in response to lipopolysaccharide, while correcting both measurements for the basal CI. We focused on the maximal CI in response to lipopolysaccharide, termed "CI max. "
To determine how well CI max level distinguished nonsurviving from surviving septic patients, receiver operating characteristic (ROC) curves were constructed for APACHE II score, SOFA score, WBC count, EA level, and CI max to determine their value in predicting 28-day mortality. The area under the ROC curve (AUC) with standard error for each variable was calculated and compared by the method of DeLong et al. (14) . The cutoff point of CI max level was then determined along the ROC curve that was most distant from the diagonal line of sensitivity and 1-specificity. Analysis of time to mortality for patients with CI max level above and below the cutoff point was compared by log-rank test. Furthermore, to evaluate efficacy of CI max for patients with septic shock, we also performed ROC and Kaplan-Meier estimates in the subgroup of patients with septic shock. Stepwise multivariate Cox regression analysis was also used to assess the covariates that were associated with time to mortality. Variables were selected on the basis of the Akaike Information Criterion (15) of all possible combinations of variables, and the subset of variables with the smallest Akaike Information Criterion value was considered the best combination.
A p value less than 0.05 was considered statistically significant. Statistical analyses were performed with SPSS for Windows version 17.0 software (SPSS, Inc., Chicago, IL).
RESULTS
Baseline Characteristics
The present study comprised 132 patients with sepsis. On ICU admission, 55 patients fulfilled the criteria for septic shock, and 38 patients fulfilled the criteria for severe sepsis without septic shock. Baseline characteristics of the study population are shown in Table 1 . Of the 132 patients, 115 survived and 17 died. All patients in this study had community-acquired infection and were admitted to the intensive care unit via the emergency department. The origin of sepsis included the abdomen (n = 40), urinary tract (n = 31), soft tissue (n = 31), lung (n = 22), and others (n = 8). There were no significant differences in age, sex, origin of sepsis, and causative microorganism between survivors and nonsurvivors. Blood samples for EAA were taken at a median of 160 minutes (interquartile range, 80 to 360 min) after admission, and there was no significant difference in the timing of blood sampling between survivors and nonsurvivors. The severity of illness, as indicated by APACHE II and SOFA scores, was significantly higher and WBC counts and CI max were significantly lower in the nonsurvivors than in the survivors (p < 0.05).
ROC Analysis
We constructed ROC curves regarding patient death within 28 days for the 5 prognostic factors assessed on admission: APACHE II score, SOFA score, WBC count, EA level, and CI max ( Fig. 2A) ( Table 2 ). We found that the AUC for CI max was 0.902, which was equivalent to the AUCs for the APACHE II score and SOFA score (p = 0.450 and p = 0.288, respectively) and which was statistically superior in comparison with WBC count and EA level (p = 0.030 and p < 0.001, respectively). In a subgroup analysis of septic shock patients, CI max yielded the highest value with an AUC of 0.885 followed by WBC count (AUC = 0.763) and APACHE II score (AUC = 0.751) (Fig. 2B, Table 3 ). The optimal threshold for CI max was 21,000 relative light units (RLU)/s. At this cutoff, the sensitivity for correct prediction of death in the ICU was 82.4% and the specificity was 92.2%. Kaplan-Meier analysis indicated that a CI max of less than 21,000 RLU/s (lower CI max group) correlated closely with poor overall patient survival compared with a CI max of more than 21,000 RLU/s (higher CI max group) (p < 0.001 by logrank test) (Fig. 3A) . Furthermore, in a subgroup analysis of septic shock patients, Kaplan-Meier analysis similarly indicated that lower CI max correlated closely with poor outcome (Fig. 3B ).
Multivariate Cox Regression Analysis
To avoid the influence caused by univariate analysis, CI max and other parameters were examined by multivariate Cox analysis. We assessed a total of eight possible confounders related to outcome: age, sex, APACHE II score, SOFA score, WBC count, EA level, sepsis categories, and CI max. Consequently, three prognostic variables were selected by stepwise selection: APACHE II score, sepsis categories, and CI max. After adjusting for APACHE II score and sepsis categories, CI max was identified as an independent significant predictor for the probability of 28-day mortality (adjusted hazard ratio, 0.99; 95% confidential interval, 0.98-1.00; p = 0.024) ( Table 4 ).
DISCUSSION
Our study revealed that measurement of CI max on admission day to the ICU was a useful predictor of mortality in patients with sepsis. According to the ROC analysis, the AUC for CI max was 0.902, which was equivalent to the AUCs for APACHE II score and SOFA score. At the optimal cutoff value of 21,000 RLU/s for CI max, the sensitivity for correct prediction of 28-day mortality was 82.4% and the specificity was 92.2%. Kaplan-Meier analysis showed that a CI max of less than 21,000 RLU/s correlated closely with poor overall patient survival. Several clinical investigations have shown predictors of mortality in patients with sepsis. Systems for scoring severity of illness are widely used in critical care settings, and numerous sepsis scoring systems have been developed. These scores (e.g., APACHE II score, SOFA score) were specifically reported to predict mortality in patients with sepsis. An increase in the APACHE II score correlates closely with the subsequent risk of hospital death for patients with sepsis (4, 16) . AUC for the SOFA score for predicting in-hospital mortality was 0.75 on admission and 0.84 at 72 hours after ICU admission (5) . The ΔSOFA was also found to have a positive relation with inhospital mortality (17, 18) . Thus, APACHE II and SOFA scores provide potentially valuable prognostic information on inhospital survival when applied to patients with sepsis.
In contrast, the value of plasma cytokine and procalcitonin, which are single biomarkers of sepsis, as predictors of mortality has remained unclear. Cytokines are important mediators in the pathophysiology of sepsis, and most are produced fairly rapidly after the onset of sepsis (19) . Increases in cytokine levels, such as those of interleukin-6, interleukin-8, interleukin-10, and tumor necrosis factor-alpha, have been reported that distinguish between survivors and nonsurvivors (20) (21) (22) (23) (24) (25) (26) (27) . However, in clinical studies, none had sufficient sensitivity and specificity to predict which patients were at greatest risk of dying from sepsis. In addition, procalcitonin has been reported to be similar to cytokines as a predictor of mortality. Although procalcitonin is useful for the diagnosis of sepsis (28) , its relation to mortality is a controversial subject because previous studies have shown that procalcitonin is not independently associated with mortality (6, 29, 30) . Thus, existing biomarkers have limited abilities to predict outcome. In the present study, CI max on ICU admission day was identified as a significant independent predictor of the probability of 28-day mortality by multivariate Cox regression analysis.
Marshall et al. reported that EA levels were significantly higher in patients who met criteria for severe sepsis (0.57 ± 0.26 vs. 0.46 ± 0.26 units; p <0.001), and the risk of severe sepsis increased with increasing increments of EA level. In addition, EA level has been found to correlate with severity of illness indices such as the APACHE II and SOFA scores (11) . Monti et al. showed that patients with high EA level who met criteria for septic patients were in need of a significantly higher dose of norepinephrine and epinephrine than were patients with intermediate and low EA levels (31) . In both studies, however, increasing EA level did not predict an increased risk of mortality.
There was no difference in EA level on admission day between survivors and nonsurvivors in the present study, and EA level was not significantly associated with 28-day mortality. Furthermore, according to the ROC analysis regarding patient death within 28 days, the AUC for EA level was significantly lower than that for CI max (p < 0.001).
We focused on chemiluminescent intensity, which is measured in the assay for calculating EA level, especially in response to a maximal dose of lipopolysaccharide, and evaluated its performance to predict mortality within 28 days in patients with sepsis on admission. ROC analysis showed that the AUC of 0.902 for CI max was equivalent to the AUCs for APACHE II score and SOFA score. In addition, Kaplan-Meier analysis showed that patients with a CI max of less than 21,000 RLU/s had poor overall survival in comparison with the patients with a CI max of more than 21,000 RLU/s. Interestingly, approximately 50% of patients in the lower CI max group died within 2 days after admission. In a subgroup analysis of septic shock patients, ROC analysis showed that the AUC of 0.89 for CI max was the highest value. Furthermore, Kaplan-Meier analysis showed that patients with high CI max (>21,000 RLU/s) yielded significantly higher rates of survival than did patients with low CI max (<21,000 RLU/s). Although the mortality rate of the septic shock patients was still high, our results indicated that high CI max on admission gives information in advance as to whether septic shock patients receiving effective therapy would remain alive. Thus, CI max appears to be a good indicator of the treatment of sepsis.
There may be two reasons why CI max was decreased in these patients. First, there was a possibility that the neutrophil count itself was decreased by severe sepsis. In our study, 10 of the 17 nonsurvivors had a WBC count of less than 4000/μL. Second, the oxidative burst activity of neutrophils might be suppressed. Martins et al. showed that oxidative burst activity due to lipopolysaccharide stimulation was significantly diminished in nonsurvivors compared with survivors among patients with sepsis (32) . Because oxidative activity is one of the factors related to the power to sterilize bacteria, its reduction is associated with immune dysfunction and high mortality (32, 33) . One limitation of the present study is that differential white blood cell count and oxidative activity of neutrophils were not evaluated, although superoxide production can be affected by a left shift of neutrophils (34, 35) . We are presently conducting a prospective cohort study focusing on the oxidative activity of neutrophils in septic patients with low CI max level. In conclusion, we showed that CI max measured on admission day to the ICU appears to have a high predictive value for mortality in patients with sepsis. Further clinical investigations are necessary to evaluate the significance of CI max in the management of patients with sepsis.
